Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (ALISON)

Media contributions

• Title	Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (ALISON)
  Degree of recognition	International
  Media name/outlet	ClinicalTrials.gov
  Media type	Web
  Date	04/02/2021
  URL	https://www.clinicaltrials.gov/ct2/show/NCT04739527
  Persons	Annegé Vledder

• Title	Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
  Degree of recognition	International
  Media name/outlet	Trial bulletin
  Media type	Web
  Date	04/02/2021
  URL	https://trialbulletin.com/lib/entry/ct-04739527
  Persons	Annegé Vledder